Journal article

The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer

M Alamgeer, V Ganju, A Szczepny, PA Russell, Z Prodanovic, B Kumar, Z Wainer, T Brown, M Schneider-Kolsky, M Conron, G Wright, DN Watkins

Thorax | BMJ PUBLISHING GROUP | Published : 2013

Abstract

Background Expression of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 has been functionally associated with a stem cell phenotype in normal and malignant cells. The prevalence of such cells in solid tumours should therefore correlate with recurrence and/ or metastasis following definitive surgical resection. The aim of this study was to evaluate the prognostic significance of ALDH1A1 and CD133 in surgically resected, early stage non-small cell lung cancer (NSCLC). Methods A retrospective analysis of ALDH1A1 and CD133 expression in 205 patients with pathologic stage I NSCLC was performed using immunohistochemistry. The association between the expression of both markers and survival was dete..

View full abstract